Home » CHINA BIOPHARMACEUTICALS COMPLETES ENSHI PHARMA ACQUISITION
CHINA BIOPHARMACEUTICALS COMPLETES ENSHI PHARMA ACQUISITION
Chinese pharmaceutical company, China Biopharmaceuticals Holdings Inc. (CHBP) has completed the acquisition of all of the shares in RACP Pharmaceutical Holdings Ltd., and its wholly owned subsidiaries, including Shenyang Enshi Pharmaceutical Co. Ltd. from RimAsia Capital Partners LP.
BioSpectrum Asia (http://www.biospectrumasia.com/content/060706CHN1073.asp)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct